No.	Recommendations/Statements	GoR	LoE	Sources
8.14. modified 2021	Consensus-based recommendation In stages IB1 and IIA1, treatment should be administered as follows: Surgery: If there are negative lymph nodes (pelvic) after surgical staging: Radical hysterectomy with resection of the medial (near the uterus) half of the parametria, with an adequate safety margin and resection within healthy margins (Piver II). With a tumor-free resection margin at the vaginal cuff (IIA1). If the tumor is < 2 cm, with no risk factors: Surgical staging with SNB and Radical hysterectomy with resection of the medial (near the uterus) half of the parametria, with an adequate safety margin and resection within healthy margins (Piver II). With a tumor-free resection margin at the vaginal cuff (IIA1). If the patient is wishing to have children and the tumor is < 2 cm without risk factors: Surgical staging with SNB and Radical trachelectomy with prophylactic permanent cerclage. If family planning has been completed: Secondary hysterectomy. If there are pelvic lymph-node metastases: Additional para-aortic lymphadenectomy (surgical staging). In postmenopausal patients: Bilateral adnexectomy. In premenopausal patients: Ovariopexy to maintain intrinsic ovarian function. If there are pelvic and/or para-aortic lymph nodes macroscopically affected by tumor: Surgical removal of the nodes, or radio(chemo)therapy. Radio(chemo)therapy: When there is histological evidence of pelvic and/or para-aortic lymph-node metastases, or several confirmed risk factors: R(CH)T. If the patient is inoperable or requests it: R(CH)T. The radiation volume should be based on the anatomy and histologically confirmed lymph-node involvement.	EC